Enhanced Pulmonary Arteriopathy in Simian Immunodeficiency Virus–infected Macaques Exposed to Morphine
- 1 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 185 (11) , 1235-1243
Abstract
Rationale: HIV-associated pulmonary arterial hypertension (PAH) is likely a more prevalent noninfectious complication of AIDS than previously recognized. Furthermore, the majority of HIV-PAH cases occur in individuals with a history of intravenous drug use. In this study we used a simian immunodeficiency (SIV) macaque model and a primary cell-culture system to investigate the association between drug abuse and HIV infection in HIV-PAH development. Methods: The archival lung tissues from macaques previously used to study the effect of morphine on SIV infection–associated neuropathogenesis were analyzed for pulmonary vascular changes. The direct effect of HIV proteins and illicit drugs was investigated on oxidative stress, survival, and proliferation of human pulmonary microvascular endothelial cells. Measurements and Main Results: SIVmacR71/17E-infected rhesus macaques treated with morphine (VM group) demonstrated significant pulmonary vascular remodeling, including the presence of early and advanced complex (plexiform) lesions, when compared with either the SIV-infected (V group) or morphine-treated uninfected (M group) macaques. However, both the V (two of five) and VM (two of six) groups included some animals with Pneumocystis jirovecii pneumonia. The endothelial cells lining the vessels with medial hypertrophy or initial-stage intimal lesions in lung sections from VM macaques demonstrated an increase in positivity for both terminal dUTP nick-end labeling and Ki67. Oxidative stress–mediated enhanced apoptosis followed by enhanced proliferation of endothelial cells was observed on simultaneous treatment with viral proteins and drugs of abuse compared with either treatment alone. Conclusions: Our findings suggest that SIV/HIV protein(s) and morphine interact to cause the proliferation of apoptosis-resistant endothelial cells leading to angio-obliteration.Keywords
This publication has 51 references indexed in Scilit:
- Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy eraAIDS, 2012
- Hypoxia-inducible factor-1 α/platelet derived growth factor axis in HIV-associated pulmonary vascular remodelingRespiratory Research, 2011
- Human immunodeficiency virus transgenic rats exhibit pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Effect of Cocaine on Human Immunodeficiency Virus–Mediated Pulmonary Endothelial and Smooth Muscle DysfunctionAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Morphine Potentiates Neuropathogenesis of SIV Infection in Rhesus MacaquesJournal of Neuroimmune Pharmacology, 2011
- Pulmonary Vascular Lesions Are Common in SIV- and SHIV- env -Infected MacaquesAIDS Research and Human Retroviruses, 2011
- Role of HIV and human herpesvirus-8 infection in pulmonary arterial hypertensionAIDS, 2008
- Pulmonary Hypertension Can Be a Sequela of Prior Pneumocystis PneumoniaThe American Journal of Pathology, 2007
- HIV-1 Nef Is Associated with Complex Pulmonary Vascular Lesions in SHIV- nef –infected MacaquesAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Increased plasma monocyte chemoattractant protein‐1 level in idiopathic pulmonary arterial hypertensionRespirology, 2006